RxDoctor Payments DataLook up a doctor →

Thomson Chemplavil, MD

Pulmonary Disease · Henderson, NVNPI 1700960150

Payments from drug & device makers

$17,325in general payments, 2019–2025

Across 779 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • GSK$2K
  • Sanofi$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Actelion Pharmaceuticals US, Inc.$1K
  • Mylan Specialty L.p.$1K
  • plus $7K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca120$3,130
GSK118$2,124
Sanofi51$1,308
Regeneron Healthcare Solutions, Inc.49$1,243
Actelion Pharmaceuticals US, Inc.44$1,095
Mylan Specialty L.p.51$1,067
Boehringer Ingelheim40$873
Jazz Pharmaceuticals Inc.22$559
Harmony Biosciences LLC19$525
Grifols USA, LLC18$453
Philips North America LLC26$388
Covis Pharma GmbH26$378
Merck18$371
Avadel CNS Pharmaceuticals, LLC15$369
Insmed, Inc.16$314
Paratek Pharmaceuticals, Inc.17$291
United Therapeutics Corporation14$287
Takeda Pharmaceuticals U.S.A., Inc.11$273
Mallinckrodt Hospital Products Inc.10$246
Verona Pharma, Inc.8$228
ANI Pharmaceuticals, Inc.8$193
Axsome Therapeutics, Inc.8$187
Sanofi-aventis U.S. LLC3$161
Teva Pharmaceuticals USA, Inc.8$151
Genentech USA, Inc.10$144
Circassia Inc.10$132
Watermark Medical, Inc.1$125
Sunovion Pharmaceuticals Inc.6$86
Amgen4$78
Gilead4$70
Inogen, Inc.5$67
Baxter Healthcare3$58
Viatris Specialty LLC2$58
Electromed, Inc.4$52
Pulmonx Corporation2$46
Melinta Therapeutics, LLC2$39
Inspire Medical Systems, Inc.1$37
Vifor Pharma, Inc.1$28
Advanced Respiratory, Inc1$25
Shionogi Inc1$22
Tactile Systems Technology Inc1$21
Breas Medical, Inc.1$21

How this compares

$17,325 in reported general payments places this provider in the 85th percentile of 84 pulmonary disease providers in Nevada.

See all pulmonary disease providers in Nevada →

Medicare billing

Part B allowed, 2024
$205,846
Medicare patients
516
Services billed
2,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Henderson

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →